Sec Form 13G Filing - AMERIPRISE FINANCIAL INC (AMP) filing for Eiger BioPharmaceuticals Inc. (EIGR) - 2023-04-10

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Amendment #5

Under the Securities and Exchange Act of 1934

 

 

Eiger BioPharmaceuticals, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

28249U105

(CUSIP Number)

February 28, 2023

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

This Schedule is filed pursuant to Rule 13d-1(b)

The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 


CUSIP NO. 28249U105

 

  1)    

  Name of Reporting Person                                                              Ameriprise Financial, Inc.

 

  S.S. or I.R.S. Identification                                                             IRS No. 13-3180631

  No. of Above Person

  2)  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☒*

 

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5)    

  Sole Voting Power

 

  0

   6)  

  Shared Voting Power

 

  7,283,215

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  8,028,922

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  8,028,922

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  18.22%

12)  

  Type of Reporting Person

 

  HC

 

*

This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.


CUSIP NO. 28249U105

 

  1)    

  Name of Reporting Person                                                              Columbia Management Investment Advisers, LLC

 

  S.S. or I.R.S. Identification                                                             IRS No. 41-1533211

  No. of Above Person

  2)  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☒*

 

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Minnesota

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5)    

  Sole Voting Power

 

  0

   6)  

  Shared Voting Power

 

  7,283,215

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  7,647,059

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  7,647,059

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  17.35%

12)  

  Type of Reporting Person

 

  IA

 

*

This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.


CUSIP NO. 28249U105

 

  1)    

  Name of Reporting Person                                                              Columbia Seligman Technology and Information Fund

 

  S.S. or I.R.S. Identification                                                              IRS No. 13-3154449

  No. of Above Person

  2)  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☒*

 

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Massachusetts

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5)     

  Sole Voting Power

 

  2,319,150

   6)   

  Shared Voting Power

 

  0

   7)   

  Sole Dispositive Power

 

  0

   8)   

  Shared Dispositive Power

 

  2,319,150

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  2,319,150

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  5.26%

12)  

  Type of Reporting Person

 

  IV

 

*

This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.


CUSIP NO. 28249U105

 

  1)    

  Name of Reporting Person                                                              Seligman Tech Spectrum (Master) Fund

 

  S.S. or I.R.S. Identification                                                             IRS No. 98-0361992

  No. of Above Person

  2)  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☒*

 

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Cayman Islands

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5)    

  Sole Voting Power

 

  2,453,966

   6)  

  Shared Voting Power

 

  0

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  2,453,966

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  2,453,966

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  5.57%

12)  

  Type of Reporting Person

 

  OO

 

*

This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.


1(a)    Name of Issuer:    Eiger BioPharmaceuticals, Inc.
1(b)    Address of Issuer’s Principal    2155 Park Boulevard
   Executive Offices:    Palo Alto, CA 94306
2(a)    Name of Person Filing:    (a) Ameriprise Financial, Inc. (“AFI”)
      (b) Columbia Management Investment
      Advisers, LLC (“CMIA”)
      (c) Columbia Seligman Technology and
      Information Fund
      (d) Seligman Tech Spectrum
      (Master) Fund
      Persons (c) and (d) are sometimes
      referred to herein as the “Funds”.
2(b)    Address of Principal Business Office:    (a) Ameriprise Financial, Inc.
      145 Ameriprise Financial Center
      Minneapolis, MN 55474
      (b) 290 Congress St.
      Boston, MA 02210
      (c) 290 Congress Street
      Boston, MA 02211
      (d) P.O. Box 309,
      Ugland House, Grand Cayman KY1-1104,
      Cayman islands
2(c)    Citizenship:    (a) Delaware
      (b) Minnesota
      (c) Massachusetts
      (d) Cayman Islands
2(d)    Title of Class of Securities:    Common Stock
2(e)    Cusip Number:    28249U105
3    Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):
  

(a) Ameriprise Financial, Inc.

  
   A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)
  

(b) Columbia Management Investment Advisers, LLC

   An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
  

(c) Columbia Seligman Technology and Information Fund

   An investment company in accordance with Rule 13d-1(b)(1)(ii)(D).


(d) Seligman Tech Spectrum (Master) Fund

An investor in accordance with Rule 13d-1(c).

 

4

Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.

CMIA and AFI do not directly own any shares of Common Stock of the issuer. As the investment adviser to the Funds and various other unregistered and registered investment companies and other managed accounts, CMIA may be deemed to beneficially own the shares reported herein by the Funds. Accordingly, the shares reported herein by CMIA include those shares separately reported herein by the Funds.

As the parent holding company of CMIA, AFI may be deemed to beneficially own the shares reported herein by CMIA. Accordingly, the shares reported herein by AFI include those shares separately reported herein by CMIA.

Each of AFI and CMIA, and the subsidiaries identified on the attached Exhibit I, disclaims beneficial ownership of any shares reported on this Schedule.

 

5

Ownership of 5% or Less of a Class: Not Applicable

 

6

Ownership of more than 5% on Behalf of Another Person:

To the knowledge of AFI, CMIA and the Funds, no other persons besides AFI, CMIA and the Funds and those persons for whose shares of common stock CMIA and AFI report beneficial ownership have the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of the securities of the issuer reported herein. As of February 28, 2023, only the Funds owned more than 5% of the class of securities reported herein.

Any remaining shares reported herein by CMIA are held by various other funds or accounts managed by CMIA which each have the right to receive any dividends paid by the issuer and could terminate their respective investment advisory relationship with CMIA and then subsequently direct the use of proceeds from the sale of the common stock owned by such fund or account. To CMIA’s knowledge, none of these other funds or accounts own more than 5% of the outstanding shares of the issuer as of February 28, 2023.

 

7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

AFI: See Exhibit I

 

8

Identification and Classification of Members of the Group:

Not Applicable

 

9

Notice of Dissolution of Group:

Not Applicable


10

Certification:

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: April 10, 2023

 

Ameriprise Financial, Inc.
By:  

/s/ Michael G. Clarke

Name: Michael G. Clarke
Title: Senior Vice President, Head of Global Operations
Columbia Management Investment
Advisers, LLC
By:  

/s/ Michael G. Clarke

Name: Michael G. Clarke
Title: Senior Vice President, Head of Global Operations
Columbia Seligman Technology and Information Fund
By:  

/s/ Michael G. Clarke

Name: Michael G. Clarke
Title: Senior Vice President & Chief Financial Officer
Seligman Tech Spectrum (Master) Fund
By:  

/s/ John Banks

Name: John Banks
Title: Director
Contact Information
Mark D. Braley
Vice President

Head of Reporting and Data Management| Global

Operations and Investor Services

Telephone: (617) 747-0663


Exhibit Index

 

Exhibit I    Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.
Exhibit II    Joint Filing Agreement